Australian scientists found that biotech mice that lacked the insulin-blocking enzyme, known as PKCepsilon, didn't develop Type 2 diabetes even after consuming a high-fat diet. Researchers may be able to avert the progression of the disease with the development of drugs that restrict the enzyme, the study's lead researcher said.

Full Story:

Related Summaries